Editorial Staff
NewsWriter.ai
@editorial-staff
Newswriter.ai is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
19779 articles
Articles
Rising Oil Prices Drive Global Shift Toward Chinese Electric Vehicle Exports
Geopolitical instability across the Middle East has pushed crude oil prices above $100 per barrel, unsettling fuel markets worldwide and reshaping buying decisions for millions of drivers. This oil shock is triggering a significant surge in global Chinese electric vehicle exports as consumers seek alternatives to fuel-depen...
March 31, 2026Read the full article
Analysts Warn Copper Market Faces Oversupply and Overvaluation Concerns
Copper prices declined by over 1% late last week to $5.43 per pound, extending a downward trend that has seen the red metal's value decrease by more than 16% from its January peak. According to analysis from Macquarie, this price correction reflects deeper concerns about copper being overpriced and oversupplied in current m...
March 31, 2026Read the full article
Venture Capital Shift Reshapes Crypto Landscape as Industry Matures
The cryptocurrency venture capital landscape is undergoing a significant transformation as investors become more selective, marking a departure from the previous boom cycle's free-flowing capital. According to Sami Start, CEO and founder of crypto infrastructure firm Transak, this shift reflects a cooling market where fundi...
March 31, 2026Read the full article
NextPlat Corp Reports 2025 Financial Results, Implements Strategic Shift Toward Higher-Margin Services
NextPlat Corp reported full-year 2025 revenue of approximately $54.3 million, representing an 18% decrease from the previous year. The decline primarily stemmed from reduced healthcare prescription volumes, though this was partially offset by growth in e-commerce sales and higher-margin services. The company's financial res...
March 31, 2026Read the full article
Crypto Startup Funding Challenges Signal Industry Maturation
Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across...
March 31, 2026Read the full article
Michelin Develops New Tires Designed to Increase Electric Vehicle Range
Michelin has developed new tires that the company states can increase the driving range of electric vehicles. This innovation comes as EV manufacturers continuously seek solutions to improve vehicle efficiency and address range anxiety among consumers.The announcement raises questions about whether major electric vehicle pr...
March 31, 2026Read the full article
Researchers Identify Androgen Hormones as Key Driver in Deadly Pediatric Brain Cancer
A research collaboration between Texas Children's Hospital, University of Pittsburgh, and Baylor College of Medicine has identified the primary driver of posterior fossa type A (PFA) ependymoma, one of the most aggressive and deadly pediatric brain cancers. The discovery centers on male sex hormones called androgens, which ...
March 31, 2026Read the full article
Planet Ventures Invests $100,000 in Space Robotics Startup General Astronautics at $40 Million Valuation
Planet Ventures Inc. has announced a $100,000 strategic investment in General Astronautics, a space robotics company selected for Y Combinator's Winter 2026 cohort. The investment was made at a $40 million post-money valuation, positioning it as part of Planet Ventures' strategy to back high-impact, frontier technologies.Ge...
March 31, 2026Read the full article
Annovis Bio's Buntanetap Development Featured in The Scientist as Phase 3 Trials Progress
Annovis Bio Inc. (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap. The company is advancing ongoing Phase 3 and extension studies in Alzheimer's disease and Parkinson's disease, with current trials showing approximately 70% en...
March 31, 2026Read the full article
Soligenix's SGX945 Gains UK Promising Innovative Medicine Designation, Strengthening Rare Disease Pipeline
Soligenix Inc. (NASDAQ: SNGX) has strengthened its rare disease pipeline as its investigational therapy SGX945 received Promising Innovative Medicine designation from United Kingdom regulatory authorities. This recognition follows previous orphan drug designation from the U.S. Food and Drug Administration for dusquetide in ...
March 31, 2026Read the full article
Fairchild Gold Adopts Semi-Annual Financial Reporting Under TSXV Pilot Program
Fairchild Gold Corp. (TSX.V: FAIR; OTCQB: FCHDF; Frankfurt: Y4Y) announced it will transition to semi-annual financial reporting under a TSX Venture Exchange pilot program. The company will adopt the framework under Coordinated Blanket Order 51-933, which permits eligible issuers to forgo first- and third-quarter financial ...
March 31, 2026Read the full article
Angkor Resources Launches IP Survey Targeting Copper-Iron Skarn System in Cambodia
Angkor Resources Corp. has commenced a 20 line-kilometre Induced Polarization geophysical survey over the Gossan Hills target on its Andong Meas mineral exploration license in Ratanakiri Province, Cambodia. The survey is designed to detect sulphide mineralization at depth, advancing one of the company's most compelling mine...
March 31, 2026Read the full article
Tonix Pharmaceuticals Reports Positive Phase 1 Data for Lyme Disease Prophylaxis Candidate TNX-4800
Tonix Pharmaceuticals Holding Corp. reported positive Phase 1 data for its investigational Lyme disease prophylaxis candidate TNX-4800, a long-acting monoclonal antibody targeting Borrelia burgdorferi. The data demonstrated rapid absorption, sustained protective levels for at least four months, and a favorable safety profil...
March 31, 2026Read the full article
Beeline Holdings Reports 127% Revenue Growth in Q4 2025, Launches Blockchain Mortgage Platform
Beeline Holdings, Inc. (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2.5 million, representing a 127% year-over-year increase. The company achieved this growth on origination volume of $84.7 million, which rose 44% from the previous year. These financial results were accompanied by improved operational efficie...
March 31, 2026Read the full article
Soligenix Reports 2025 Results with Phase 3 CTCL Trial Progress and Orphan Drug Designation Momentum
Soligenix Inc. (NASDAQ: SNGX) reported its 2025 results, emphasizing substantial progress across its rare disease development pipeline. The company highlighted the advancement of its Phase 3 FLASH2 trial evaluating HyBryte(TM) (SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL). An interim analysis for this trial...
March 31, 2026Read the full article
Nutriband Selects Global Brand Name for AVERSA Fentanyl Patch, Targets $80M-$200M U.S. Market
Nutriband Inc. (NASDAQ: NTRB) has selected a proposed worldwide brand name for its abuse-deterrent fentanyl transdermal system, with plans to submit the name and product labeling to the FDA and international regulators while filing for trademark protection. The product, developed using the company's AVERSA technology, could...
March 31, 2026Read the full article
Canamera Energy Metals Secures $10.2 Million to Advance Rare Earth Exploration Across Three Countries
Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) (FSE: 4LF0) has raised approximately $10.2 million over the past four months, providing capital to execute near-term exploration programs across its portfolio of seven projects. The financing supports the company's strategy of building a portfolio of district-scale rar...
March 31, 2026Read the full article
Ketryx Launches Model Context Protocol Beta to Integrate Compliance Intelligence into AI Development Tools
Ketryx, an AI-native compliance platform for safety-critical product development, has launched the beta version of its Model Context Protocol server. This development enables artificial intelligence tools including ChatGPT, Claude, and Copilot to securely access live compliance data directly from the Ketryx platform. The in...
March 31, 2026Read the full article
Lantern Pharma Advances AI-Driven Oncology Pipeline Toward 2026 Milestones
Lantern Pharma reported fourth-quarter and full-year 2025 operational highlights marked by continued progress in its LP-300 Phase 2 HARMONIC trial, completion of targeted enrollment in Japan, and planned protocol discussions with the FDA in mid-May 2026. The company also advanced LP-184, LP-284 and STAR-001 across multiple ...
March 31, 2026Read the full article
Cardio Diagnostics Leverages AI and Epigenetics to Transform Cardiovascular Disease Detection
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, is developing solutions to address cardiovascular disease, the leading cause of death in the United States. The company's proprietary platform integrates epigenetic and genetic biomarkers with artif...
March 31, 2026Read the full article
Verified First and isolved Partnership Streamlines Employee Screening and Compliance
Verified First has partnered with isolved® to unify background screening, post-hire rescreening, and I-9 management within isolved People Cloud™. This partnership expands access to a streamlined screening experience that keeps HR teams focused on hiring without complex integrations.
March 31, 2026Read the full article